Literature DB >> 2438805

Evidence for the receptor-operated calcium channels in human platelet plasma membrane.

P V Avdonin, I B Cheglakov, E M Boogry, I V Svitina-Ulitina, A V Mazaev, V A Tkachuk.   

Abstract

Loading of human platelets with quin2 considerably increases platelet activating factor (PAF)-induced 45Ca2+ uptake. 45Ca2+ binding in the absence of agonists remains unchanged. The data show that PAF stimulates calcium ion influx into platelets, since quin2 provides substantial additional buffer capacity for Ca2+ in the cytoplasm. PAF and prostaglandin endoperoxide H2 analogue, U46619, induce Ba2+ and Mn2+ entry. The entrance of these cations and the rise in [Ca2+]i are both blocked by cAMP elevation and activation of protein kinase C by phorbol ester which indicates a single mechanism for agonist-induced transport of all three cations into platelets. It is assumed that agonists stimulate Ca2+ entry through the receptor-operated channels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438805     DOI: 10.1016/0049-3848(87)90204-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  Inositol phospholipid turnover in PAF transmembrane signalling.

Authors:  S D Shukla
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Receptor-operated channels in human platelets.

Authors:  V A Tkachuk; P V Avdonin; I B Cheglakov; V N Bochkov
Journal:  J Protein Chem       Date:  1989-06

3.  Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.

Authors:  S Allen; S Khan; F Al-Mohanna; P Batten; M Yacoub
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation.

Authors:  M Hahn; V A Tkachuk; V N Bochkov; I B Cheglakov; J P Clozel
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.